Literature DB >> 23910012

Potential contribution of interleukin-33 to the development of interstitial lung disease in patients with primary Sjogren's Syndrome.

Lin Zhao1, Lutian Yao, Lin Yuan, Liping Xia, Hui Shen, Jing Lu.   

Abstract

OBJECTIVE: To determine whether interleukin (IL)-33 and soluble ST2 (sST2) are associated with primary Sjogren's Syndrome (pSS).
METHODS: Serum levels of IL-33 and sST2 in 110 pSS patients and 78 healthy controls were measured by enzyme-linked immunosorbent assay (ELISA). Immunoglobulins, rheumatoid factors (RF), antinuclear antibody (ANA), anti-SSA/RO-52 antibody, anti-SSB antibody and erythrocyte sedimentation rate (ESR) were measured by standard laboratory techniques. Interstitial lung disease (ILD) was identified on high-resolution computed tomography (HRCT). Disease activity in pSS was scored with the European League Against Rheumatism Sjogren's Syndrome Disease Activity Index (ESSDAI).
RESULTS: Serum levels of IL-33 and sST2 were significantly elevated in pSS patients, especially in patients with ILD. There was significant positive correlation between IL-33 and RF, anti-SSB antibody.
CONCLUSION: IL-33/sST2 may be involved in the pathogenesis of pSS and partly contribute to the ILD in pSS patients.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Interleukin-33; Interstitial lung disease; Primary Sjogren’s Syndrome; sST2

Mesh:

Substances:

Year:  2013        PMID: 23910012     DOI: 10.1016/j.cyto.2013.07.006

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

1.  The role of ST2 and ST2 genetic variants in schistosomiasis.

Authors:  Xin Long; Michelle Daya; Jianping Zhao; Nicholas Rafaels; Huifang Liang; Joseph Potee; Monica Campbell; Bixiang Zhang; Maria Ilma Araujo; Ricardo R Oliveira; Rasika A Mathias; Li Gao; Ingo Ruczinski; Steve N Georas; Donata Vercelli; Terri H Beaty; Kathleen C Barnes; Xiaoping Chen; Qian Chen
Journal:  J Allergy Clin Immunol       Date:  2017-02-09       Impact factor: 10.793

2.  Transcription factor Hes1 modulates osteoarthritis development in cooperation with calcium/calmodulin-dependent protein kinase 2.

Authors:  Shurei Sugita; Yoko Hosaka; Keita Okada; Daisuke Mori; Fumiko Yano; Hiroshi Kobayashi; Yuki Taniguchi; Yoshifumi Mori; Tomotake Okuma; Song Ho Chang; Manabu Kawata; Shuji Taketomi; Hirotaka Chikuda; Haruhiko Akiyama; Ryoichiro Kageyama; Ung-Il Chung; Sakae Tanaka; Hiroshi Kawaguchi; Shinsuke Ohba; Taku Saito
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-02       Impact factor: 11.205

Review 3.  The Involvement of Alarmins in the Pathogenesis of Sjögren's Syndrome.

Authors:  Julie Sarrand; Laurie Baglione; Dorian Parisis; Muhammad Soyfoo
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

4.  Are soluble ST2 levels in the picogram or nanogram range in serum of healthy subjects/disease patients?

Authors:  Rohit Saluja
Journal:  J Korean Med Sci       Date:  2014-01       Impact factor: 2.153

5.  Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease.

Authors:  Sachiko Furukawa; Masafumi Moriyama; Kensuke Miyake; Hitoshi Nakashima; Akihiko Tanaka; Takashi Maehara; Mana Iizuka-Koga; Hiroto Tsuboi; Jun-Nosuke Hayashida; Noriko Ishiguro; Masaki Yamauchi; Takayuki Sumida; Seiji Nakamura
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

6.  Umbilical cord mesenchymal stem cells alleviate Sjögren's syndrome and related pulmonary inflammation through regulating Vγ4+ IL-17+ T cells.

Authors:  Yan Cong; Xiaojun Tang; Dandan Wang; Zhuoya Zhang; Saisai Huang; Xin Zhang; Genhong Yao; Lingyun Sun
Journal:  Ann Transl Med       Date:  2022-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.